Henriette is CEO of Pfizer France since 2018.
With more than 22 years of experience in the pharmaceuticals industry field, she has in-depth knowledge of healthcare issues.
In 2003, she joined Pfizer Denmark, where she held various positions, in particular in oncology, before being appointed CEO of Pfizer Denmark in 2014.
She chaired the Board of the Danish Association of the Pharmaceutical Industry (LIF) and was member of the Policy Board of the Confederation of Danish Industry.
Henriette Dræbye Rosenquist has a Master of Science Pharmacy from Københavns Universitet - University of Copenhagen and a Master of Executive MBA from Henley Business School, in addition she pursued a course at INSEAD Paris.